Bill Snyder

November 17, 2016

Graduate student’s cancer studies land NCI support

Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University.

By Bill Snyder
November 7, 2016

Early study finds antibody that ‘neutralizes’ Zika virus

Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have isolated a human monoclonal antibody that in a mouse model “markedly reduced” infection by the Zika virus.

By Bill Snyder
November 3, 2016

Address outlines VUMC’s strategic direction

In his State of the Medical Center address on Wednesday, Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center (VUMC), and Dean of the Vanderbilt University School of Medicine, described a “Strategic Compass” to help the Medical Center continue to “grow and shine” in the years to come.

By Bill Snyder
November 3, 2016

Brown named interim director of Institute of Chemical Biology

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).

By Bill Snyder
October 27, 2016

Vanderbilt’s Dugan, Patel, Wallace set for Discovery Lecture

Three Vanderbilt University neuroscientists on the forefront of research in autism, addiction and Alzheimer’s disease will discuss their cutting-edge investigations during the next Flexner Discovery Lecture on Thursday, Nov. 3.

By Bill Snyder
October 27, 2016

Iadecola set for Oates Lectureship in Clinical Pharmacology

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.

By Bill Snyder
October 21, 2016

DNA damage response protein

Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome.
By Bill Snyder
October 20, 2016

Preparing for a return of pox

To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people.
By Bill Snyder
October 20, 2016

Research sheds light on how RSV wards off potential vaccines

Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it.
By Bill Snyder
October 13, 2016

EGF receptor found to regulate macrophage inflammation in gut

Researchers at Vanderbilt University School of Medicine have uncovered a link between epidermal growth factor receptor (EGFR) signaling and the inflammatory response to bacterial infection in the gastrointestinal tract.
By Bill Snyder
October 13, 2016

Grant spurs research on how nerves guide organ function

Michelle Southard-Smith, Ph.D., associate professor of Medicine in the Vanderbilt University School of Medicine, has won a major award from the National Institutes of Health (NIH) to support her research on how nerves control organ function.
By Bill Snyder
October 13, 2016

Autoimmune diseases expert Kappler set for next Discovery Lecture

John Kappler, Ph.D., a pioneer in the study of autoimmune diseases, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Oct. 20, in room 208 Light Hall.
By Bill Snyder
1 … 71 72 73 74 75 … 115